Adjuvant chemotherapy in the patients with stage II colon cancer that have MSI-H status and poor prognostic factors : to give or not to give?
Not Applicable
Recruiting
- Conditions
- To find out if the patients with stage II colon cancer that have MSI-H and poor prognostic factors gain the survival benefit (disease-free and overall survival) of adjuvant chemotherapy or notColon cancerStage IIPoor prognostic factorMSIadjuvant chemotherapy
- Registration Number
- TCTR20180329003
- Lead Sponsor
- Ratchadapiseksompoch
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
-Patients with pathologically confirmed stage II colon cancer with poor prognostic factors
-Age > 18 years
-Available tissue specimen for MMR testing
Exclusion Criteria
-Not available tissue specimen for MMR testing
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disease free survival, overall survival 5 years after the operation Kaplan meier method
- Secondary Outcome Measures
Name Time Method complication from treatment 6 months after the adjuvant chemotherapy percentage